Digital Pathology Market Size Share and Industry Outlook to 2028

SKU: DMPH1019 | Last Updated On: Jan 12 2022 | No. of Pages: 180 | Available Formats

> Global Digital Pathology Market Expected to reach a high CAGR of 11.80% By 2028: DataM Intelligence

Global Digital Pathology Market is Segmented  By Product(Software, Scanners, Storage Systems, Communication Systems), By Application(Drug Discovery, Teleconsultation, Diagnosis, Training & Education), By Type(Human Pathology, Veterinary Pathology), By Technology(Whole Slide Imaging, Telepathology(Static Telepathology, Dynamic Telepathology)), By End-user(Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research & Academic Institutes, Hospital laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis,2021-2028

 

Market Overview

The Global "Digital Pathology Market" is expected to grow at a CAGR of 11.80% during the forecast period (2021-2028).

Digital pathology is a dynamic, image-based environment that is enabled in part by virtual microscopy and that can view, manage and analyze the pathology information generated from a digitized glass slide. Healthcare applications consist of diagnosis, diagnostic consultation, medical training, clinical research, among many other applications. With the introduction of Whole-Slide Imaging, the field of digital pathology is currently regarded as one of the most promising avenues of diagnostic medicine to achieve an even faster and cheaper diagnosis, the prognosis of essential diseases.

Market Dynamics

The global market for the Digital Pathology Market is primarily driven by the rising prevalence of chronic conditions, high adoption of digital pathology systems and its accuracy in the pathological assessment. According to the World Health Organization, The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2019. WHO estimated that Infectious diseases kill over 17 million people a year, around the world. Additionally, the rising demand for personalized medicine, its advantage in reducing human error and improve the accuracy of diagnoses, increases the potential for using data for education and consultations and rapid technological advancements in digital pathology are expecting to play a crucial role in the development of the market.

However, lack of reimbursement policies and the high cost of digital pathology systems may hinder the market progress. According to a national survey conducted on behalf of National Cancer Research Institute’s CM-Path initiative in UK, 82.5% of respondents agreed that initial financial cost was an obstacle to widespread usage of digital pathology in their institution. On the other hand, only 15% agreed that safety concerns were hampering more widespread use of digital slides.

Segmentation Analysis

By Product, the Global Digital Pathology Market is segmented into Software, Scanners, Storage Systems, and Communication Systems. The software market share is expected to witness the highest growth rate due to the availability of analytical, user-friendly, and advanced functions for pathology diagnosis. Technological advancements and product launches by key players are some factors that are anticipated to amplify the segment growth. For instance, in April 2019, Gestalt Diagnostics announced their development of an artificial intelligence algorithm that identifies and routes more critical cases first to the appropriate pathologist based upon a pathologist's specialty.

By Application, the Global Digital Pathology Market is segmented into Drug Discovery, Teleconsultation, Diagnosis, and Training & Education. The diagnosis sector accounts for a significant market share, in terms of revenue owing to the rising prevalence of diseases such as cancer. Additionally, the increasing attention of manufacturers on developing rapid and accurate diagnostic techniques is likely to encourage the growth of the segment.

By Technology, the Global Digital Pathology Market is segmented into Whole Slide Imaging and Telepathology. Telepathology is sub-segmented into static and dynamic. The Whole Slide Imaging segment dominates the market due to increasing acceptance and adoption of this system for academic research activities and enhanced resolution of the image.

In the Telepathology share, the static system held a significant percentage of the segment owing it to its advantages such as cost-effectiveness, efficiency, and reliability. Though adoption of Telepathology is relatively low increasing R&D on applications of static and dynamic systems is expected to affect the usage rate of this technology positively. For instance, Hybrid Telepathology, which is the combination of static and dynamic telepathology, is expected to gain popularity as it has advantages of both the systems.

By Type, the digital pathology market is bifurcated into human and veterinary pathology. The human pathology segment accounts for the largest share of the market owing to the increasing number of cancer research activities.

Geographical Share

Geographically, the global market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.

North America is the leading revenue contributor to the global market and is followed by Europe. It can be attributed to the rising in acceptance of the digital pathology system in the region and increasing incidents of cancer and chronic diseases. According to the estimates of the American Cancer Society, in 2018, there were 1,735,350 new cancer cases diagnosed, and in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States.

Other factors such as growing investments in R&D activities, favorable reimbursement policies, supportive government initiatives on the development of technologically advanced systems, and a strong presence of major players in the regions are supplementing the market growth of these regions. For instance, in April 2019, the UK invested $65M to set up five new AI digital pathology and imaging centers. Philips, GE Healthcare, Siemens and Leica are some of the companies that will be leading the new centers, according to the Department for Business, Energy and Industrial Strategy.

Asia Pacific is anticipated to exhibit the fastest CAGR during the forecast period due to the presence of a large patient population, improving healthcare infrastructure coupled with growing investments in the medical field, and demand for novel treatment options.

Competitive Trends

Key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. New product launches and R&D are other ways the leading players improve their market presence.

In April 2019, International medical imaging IT and cybersecurity company Sectra signed a digital pathology contract with the Region of Southern Denmark. The IT solution for handling digital pathology images will enable pathologists at the region's four hospitals to review and collaborate around cases in a way that is not possible with microscopes. This will increase efficiency in primary diagnostics, thereby improving cancer care.

In April 2019, HCG introduced US FDA approved digital pathology solution by Philips Intellisite Pathology Solutions across all its centers in India. This technology marks a step forward in cancer treatment through precision, speed, efficiency, and ease of use with immense potential to provide significant clinical benefits to both the physicians and patients.

In April 2019, Deep Lens Inc., a U.S.-based AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis raised $14 million in Series A funding. The Series A round was led by Northpond Ventures with participation from existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners.

In April 2019, Cancer informatics and digital pathology workflow solution provider Inspirata Europe Ltd announced their intention to bring two new artificial intelligence tools for surveillance, structuring, and reporting of pathology diagnoses to the UK and Ireland markets.

In January 2019, Roche announced the launch of its uPath enterprise software for digital pathology. uPath enhances the user experience by drastically decreasing image rendering times, integrating automated image analysis and improving efficiency by enabling an improved workflow for sharing cases between pathologists.

In December 2018, Cancer informatics and digital pathology workflow solution provider Inspirata Europe, Ltd. announced it has entered into a partnership agreement with Hamamatsu Photonics affording shared customers with the ability to view native Hamamatsu .ndpi images within Inspirata’s Dynamyx digital pathology software.

Key Takeaways

  • The global market for the Digital Pathology Market is primarily driven by the rising prevalence of chronic conditions, high adoption of digital pathology systems and its accuracy in the pathological assessment.

  • The software market share is expected to witness the highest growth rate due to the availability of analytical, user-friendly, and advanced functions for pathology diagnosis. The diagnosis sector accounts for a significant market share, in terms of revenue owing to the rising prevalence of diseases such as cancer.

  • North America is the leading revenue contributor to the global market and is followed by Europe. It can be attributed to the rising in acceptance of the digital pathology system in the region and increasing incidents of cancer and chronic diseases.

  • Key players are adopting strategies such as mergers and collaborations to stand out as strong competitors in the market. For instance, in December 2018, Inspirata Europe, Ltd. announced it has entered into a partnership agreement with Hamamatsu Photonics.

Why Purchase the Report?

  • Visualize the composition of the global Digital Pathology Market across each indication, in terms of Product and Application options, highlighting the key commercial assets and players.

  • Identify commercial opportunities in global Digital Pathology Market by analyzing trends and co-development deals.

  • Excel data sheet with thousands of data points of the global Digital Pathology Market - level 4/5 segmentation.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the key products of all major market players

Target Audience:

  • Equipment Suppliers/ Buyers

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

Trending Topics:

Anatomic Pathology Market

Anti-Suicide Drugs Market

 

Table of Contents

1. Digital Pathology Market – Methodology and Scope

1.1. Research methodology

1.2. Research Objective and Scope of the Report

2. Digital Pathology Market – Market Definition and Overview

3. Digital Pathology Market – Executive Summary

3.1. Market Snippet by Product

3.2. Market Snippet by Application

3.3. Market Snippet by Technology

3.4. Market Snippet by End-user

3.5. Market Snippet by Region

4. Digital Pathology Market – Market Dynamics

4.1. Market Impacting Factors

4.1.1. Drivers

4.1.1.1. Growing trend of digitalization in medical sector

4.1.1.2. Increasing prevalence of chronic diseases and cancer

4.1.1.3. Greater cost efficiency 

4.1.1.4. Driver 4

4.1.2. Restraints

4.1.2.1. High Cost of Digital Pathology Systems

4.1.2.2. Restraint 2

4.1.3. Opportunity

4.1.4. Impact Analysis

5. Digital Pathology Market – Industry Analysis

5.1. Porter's Five Forces Analysis

5.2. Supply Chain Analysis

5.3. Pricing Analysis

5.4. Regulatory Analysis

5.5. Patent Analysis

6. Digital Pathology Market – By Product

6.1. Software

6.2. Scanners

6.3. Storage Systems

6.4. Communication Systems

7. Digital Pathology Market – By Application

7.1. Drug Discovery

7.2. Teleconsultation

7.3. Diagnosis

7.4. Training & Education

8. Digital Pathology Market – By Type

8.1. Human Pathology

8.2. Veterinary Pathology

9. Digital Pathology Market – By Technology

9.1. Whole Slide Imaging

9.2. Telepathology

9.2.1. Static Telepathology

9.2.2. Dynamic Telepathology

10. Digital Pathology Market – By End-user

10.1. Pharmaceutical and Biotechnology Companies

10.2. Contract Research Organizations

10.3. Research & Academic Institutes

10.4. Hospital laboratories

11. Digital Pathology Market – By Region

11.1. North America

11.1.1. U.S.

11.1.2. Canada

11.1.3. Mexico

11.2. Europe

11.2.1. Germany

11.2.2. U.K.

11.2.3. France

11.2.4. Italy

11.2.5. Spain

11.2.6. Rest of Europe

11.3. South America

11.3.1. Brazil

11.3.2. Argentina

11.3.3. Rest of South America

11.4. Asia Pacific

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. Australia

11.4.5. Rest of Asia Pacific

11.5. The Middle East and Africa

12. Digital Pathology Market – Competitive Landscape

12.1. Competitive Scenario

12.2. Competitor Strategy Analysis

12.3. Comparative Product Portfolio Analysis

12.4. Market Positioning/Share Analysis

12.5. Mergers and Acquisitions Analysis

13. Digital Pathology Market – Company Profiles

13.1. Philips Healthcare 

13.2. 3DHistech Inc.

13.3. Hamamatsu Photonics

13.4. Ventana Medical Systems Inc.

13.5. GE Healthcare

13.6. Leica Biosystems

13.7. Definiens AG

13.8. Olympus Corporation

13.9. Inspirata Co.

13.10. MicroSkan Technologies

13.11. Roche Group

14. Digital Pathology Market – Premium Insights

15. Digital Pathology Market – DataM

15.1. Appendix

15.2. About Us and Services

15.3. Contact Us

List of Tables & Figures

List of Tables

Table 01 Global digital pathology value, 2018, 2022 & 2026 (us$ mn), by product, 

Table 02 Global digital pathology value, 2018, 2022 & 2026 (us$ mn), by application

Table 03 Global digital pathology value, 2018, 2022 & 2026 (us$ mn), by technology, 

Table 03 Global digital pathology value, 2018, 2022 & 2026 (us$ mn), by type, 

Table 04 Global digital pathology value, 2018, 2022 & 2026 (us$ mn), by end-user, 

Table 05 Global digital pathology value 2018, 2022 & 2026 (us$ mn), by region, 

Table 06. Global digital pathology share 2018, 2022 & 2026 (%), by product 

Table 07.  Global digital pathology value (us$ mn), by product, 2018–2026 

Table 08 Global digital pathology share 2018, 2022 & 2026 (%), by application 

Table 09 Global digital pathology value (us$ mn), by application, 2018–2026

Table 10 Global digital pathology share 2018, 2022 & 2026 (%), by technology 

Table 11 Global digital pathology value (us$ mn), by technology, 2018–2026 

Table 11 Global digital pathology value (us$ mn), by type, 2018–2026 

Table 12 Global digital pathology share 2018, 2022 & 2026 (%), by end-user 

Table 13.  Global digital pathology value (us$ mn), by end-user, 2018–2026 

Table 14 Global digital pathology share 2018, 2022 & 2026 (%), by region 

Table 15 Global digital pathology value (us$ mn), by region, 2018–2026 

Table 16 North America digital pathology value (us$ mn), by product, 2018–2026 

Table 17 North America digital pathology value (us$ mn), by application, 2018–2026

Table 18 North America digital pathology value (us$ mn), by technology, 2018–2026 

Table 18 North America digital pathology value (us$ mn), by type, 2018–2026 

Table 19 North America digital pathology value (us$ mn), by end-user, 2018–2026

Table 20 North America digital pathology value (us$ mn), by country, 2018–2026 

Table 21 South America digital pathology value (us$ mn), by product, 2018–2026 

Table 22 South America digital pathology value (us$ mn), by application, 2018–2026

Table 23 South America digital pathology value (us$ mn), by technology, 2018–2026 

Table 23 South America digital pathology value (us$ mn), by type, 2018–2026

Table 24 South America digital pathology value (us$ mn), by end-user, 2018–2026

Table 25.  South America digital pathology value (us$ mn), by country, 2018–2026 

Table 26 Europe digital pathology value (us$ mn), by product, 2018–2026 

Table 27 Europe digital pathology value (us$ mn), by application, 2018–2026

Table 28 Europe digital pathology value (us$ mn), by technology, 2018–2026 

Table 28 Europe digital pathology value (us$ mn), by type, 2018–2026

Table 29.  Europe digital pathology value (us$ mn), by end-user, 2018–2026 

Table 30 Europe digital pathology value (us$ mn), by country, 2018–2026 

Table 31 Asia pacific digital pathology value (us$ mn), by product, 2018–2026 

Table 32 Asia pacific digital pathology value (us$ mn), by application, 2018–2026 

Table 33 Asia pacific digital pathology value (us$ mn), by technology, 2018–2026 

Table 33 Asia pacific digital pathology value (us$ mn), by type, 2018–2026

Table 34 Asia pacific digital pathology value (us$ mn), by end-user, 2018–2026 

Table 35 Asia pacific digital pathology value (us$ mn), by country, 2018–2026 

 

Table 36.   The Middle East & Africa digital pathology value (us$ mn), by product, 2018–2026 

Table 37.   The Middle East & Africa digital pathology value (us$ mn), by application, 2018–2026 

Table 38 The Middle East & Africa digital pathology value (us$ mn), by technology, 2018–2026 

Table 38 The Middle East & Africa digital pathology value (us$ mn), by type, 2018–2026 

Table 39.   The Middle East & Africa digital pathology value (us$ mn), by end-user, 2018–2026 

Table 40.   The Middle East & Africa digital pathology value (us$ mn), by country, 2018–2026 

Table 41 Philips healthcare inc.: an overview

Table 42.  Philips healthcare inc.: product portfolio

Table 43.  Philips healthcare inc.: key developments

Table 44 3dhistech inc.: overview

Table 45 3dhistech inc.: product portfolio

Table 46 3dhistech inc.: key developments

Table 47 Olympus Corporation: an overview

Table 48 Olympus corporation: product portfolio

Table 49 Olympus Corporation: key developments

Table 50 Ventana medical systems inc.: an overview

Table 51  Ventana medical systems inc.: product portfolio

Table 52  Ventana medical systems inc.: key developments

Table 53  Inspirata co.: overview

Table 54  Inspirata co.: product portfolio

Table 55  Inspirata co.: key developments

Table 56  Hamamatsu photonics: an overview

Table 57  Hamamatsu photonics: product portfolio

Table 58 Hamamatsu photonics: key developments

Table 59 Ge healthcare: an overview

Table 60 Ge healthcare: product portfolio

Table 61 Ge healthcare: key developments

Table 62 Leica biosystems: an overview

Table 63 Leica biosystems: product portfolio

Table 64 Leica biosystems: key developments

Table 65 Microskan technologies: an overview

Table 67.  Microskan technologies: product portfolio

Table 68 Microskan technologies: key developments

Table 69 Definiens ag: an overview

Table 70 Definiens ag: product portfolio

Table 71 Definiens ag: key developments

 

List of Figures

Figure 01 Global digital pathology share, 2018 & 2026 (%), by application

Figure 02 Global digital pathology share, 2018 & 2026 (%), by product

Figure 03 Global digital pathology share, 2018 & 2026 (%), by technology

Figure 03 Global digital pathology share, 2018 & 2026 (%), by type

Figure 04 Global digital pathology share, 2018 & 2026 (%), by end-user

Figure 05 Global digital pathology share, 2018 & 2026 (%), by region

Figure 06 Global digital pathology value, 2018 - 2026 (us$ mn) and year on year growth

Figure 07 Global digital pathology year on year growth 2018 to 2026 (%), by product

Figure 08 Global digital pathology value (us$ mn), by software, 2018–2026 

Figure 09.  Global digital pathology value (us$ mn), by scanners, 2018–2026 

Figure 10.  Global digital pathology value (us$ mn), by storage systems, 2018–2026 

Figure 11.  Global digital pathology value (us$ mn), by communication systems, 2018–2026 

Figure 12 Global digital pathology share (%), by product, 2018 & 2026

Figure 13 Global digital pathology year on year growth 2018 to 2026 (%), by application

Figure 14 Global digital pathology value (us$ mn), by drug discovery 2018–2026 

Figure 15  Global digital pathology value (us$ mn), by teleconsultation 2018–2026 

Figure 16 Global digital pathology value (us$ mn), by diagnosis 2018–2026 

Figure 17  Global digital pathology value (us$ mn), by training & education 2018–2026 

Figure 18  Global digital pathology share (%), by application, 2018 & 2026

Figure 19 Global digital pathology year on year growth 2018 to 2026 (%), by technology

Figure 20 Global digital pathology value (us$ mn), by whole slide imaging 2018–2026 

Figure 21.  Global digital pathology value (us$ mn), by telepathology 2018–2026 

Figure 22  Global digital pathology share (%), by technology, 2018 & 2026

Figure 19 Global digital pathology year on year growth 2018 to 2026 (%), by type

Figure 20 Global digital pathology value (us$ mn), by human pathology 2018–2026 

Figure 21.  Global digital pathology value (us$ mn), by veterinary pathology 2018–2026 

Figure 22  Global digital pathology share (%), by type, 2018 & 2026

Figure 23 Global digital pathology year on year growth 2018 to 2026 (%), by end-user

Figure 24  Global digital pathology value (us$ mn), by pharmaceutical and biotechnology companies, 2018–2026 

Figure 25 Global digital pathology value (us$ mn), by contract research organizations, 2018–2026 

Figure 26  Global digital pathology value (us$ mn), by research & academic institutes, 2018–2026 

Figure 27 Global digital pathology value (us$ mn), by hospital laboratories, 2018–2026 

Figure 28  Global digital pathology share (%), by end-user, 2018 & 2026

Figure 29 Global digital pathology year on year growth 2018 to 2026 (%), by region

Figure 30    north america digital pathology value (us$ mn), 2018–2026 

Figure 31  north america digital pathology value (us$ mn), by product, 2018–2026 

Figure 32 North america digital pathology value (us$ mn), by application, 2018–2026

Figure 33  north america digital pathology value (us$ mn), by end-user, 2018–2026 

Figure 34   north america digital pathology value (us$ mn), by technology, 2018–2026 

Figure 34   north america digital pathology value (us$ mn), by type, 2018–2026 

Figure 35  north america digital pathology value (us$ mn), by country, 2018–2026 

Figure 36   south america digital pathology value (us$ mn), 2018–2026 

Figure 37  south america digital pathology value (us$ mn), by product, 2018–2026 

Figure 38 South america digital pathology value (us$ mn), by application, 2018–2026

Figure 39 South america digital pathology value (us$ mn), by end-user, 2018–2026 

Figure 40   south america digital pathology value (us$ mn), by technology, 2018–2026 

Figure 40   south america digital pathology value (us$ mn), by type, 2018–2026 

Figure 41  south america digital pathology value (us$ mn), by country, 2018–2026 

Figure 42   europe digital pathology value (us$ mn), 2018–2026 

Figure 43  europe digital pathology value (us$ mn), by product, 2018–2026 

Figure 44 Europe digital pathology value (us$ mn), by application, 2018–2026 

Figure 45   europe digital pathology value (us$ mn), by end-user, 2018–2026 

Figure 46   europe digital pathology value (us$ mn), by technology, 2018–2026 

Figure 46   europe digital pathology value (us$ mn), by type, 2018–2026

Figure 47  europe digital pathology value (us$ mn), by country, 2018–2026 

Figure 48    asia pacific digital pathology value (us$ mn), 2018–2026 

Figure 49  asia pacific digital pathology value (us$ mn), by product, 2018–2026 

Figure 50 Asia pacific digital pathology value (us$ mn), by application, 2018–2026

Figure 51   asia pacific digital pathology value (us$ mn), by end-user, 2018–2026 

Figure 52   asia pacific digital pathology value (us$ mn), by technology, 2018–2026 

Figure 52   asia pacific digital pathology value (us$ mn), by type, 2018–2026 

Figure 53  asia pacific digital pathology value (us$ mn), by country, 2018–2026 

Figure 54    middle east and africa digital pathology value (us$ mn), 2018–2026 

Figure 55     middle east and africa digital pathology value (us$ mn), by product, 2018–2026 

Figure 56   Middle east and africa digital pathology value (us$ mn), by application, 2018–2026

Figure 57    middle east and africa digital pathology value (us$ mn), by end-user, 2018–2026 

Figure 58     middle east and africa digital pathology value (us$ mn), by technology, 2018–2026 

Figure 58     middle east and africa digital pathology value (us$ mn), by type, 2018–2026 

Figure 59     middle east and africa digital pathology value (us$ mn), by country, 2018–2026 

Figure 60 Philips healthcare inc.: financials

Figure 61 3dhistech inc.: financials

Figure 62 Hamamatsu photonics: financials

Figure 63 Ventana medical systems inc.: financials

Figure 64 Inspirata co.: financials

Figure 65 Ge healthcare: financials

Figure 66 Leica biosystems: financials

Figure 67 Definiens ag: financials

Figure 68 Olympus corporation: financials

Figure 69 Microskan technologies: financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest